Does the kynurenine pathway play a pathogenic role in autism spectrum disorder?
Open Access
- 6 August 2024
- journal article
- research article
- Published by Elsevier in Brain, Behavior, & Immunity - Health
- Vol. 40, 100839
Abstract
No abstract availableKeywords
This publication has 107 references indexed in Scilit:
- Sex-Specific Neurodevelopmental Outcomes Among Offspring of Mothers With SARS-CoV-2 Infection During PregnancyJAMA Network Open, 2023
- Psychological Comorbidities in Autism Spectrum Disorder2020
- Maternal immune activation, central nervous system development and behavioral phenotypesBirth Defects Research, 2018
- Prenatal kynurenine exposure in rats: age-dependent changes in NMDA receptor expression and conditioned fear respondingPsychopharmacology, 2016
- Altered kynurenine pathway metabolism in autism: Implication for immune‐induced glutamatergic activityAutism Research, 2015
- Analysis of CHRNA7 rare variants in autism spectrum disorder susceptibilityAmerican Journal of Medical Genetics Part A, 2015
- Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood AutismJAMA, 2013
- Microglial Activation in Young Adults With Autism Spectrum DisorderJAMA Psychiatry, 2013
- Prenatal exposure to an NMDA receptor antagonist, MK-801 reduces density of parvalbumin-immunoreactive GABAergic neurons in the medial prefrontal cortex and enhances phencyclidine-induced hyperlocomotion but not behavioral sensitization to methamphetamine in postpubertal ratsPsychopharmacology, 2007
- Effects of Tryptophan Depletion in Drug-Free Adults With Autistic DisorderArchives of General Psychiatry, 1996